We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
+5.83%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
–
AUM
$288M
AUM Growth
+$11.3M
Cap. Flow
-$1.59M
Cap. Flow %
-0.55%
Top 10 Hldgs %
61.3%
Holding
95
New
4
Increased
57
Reduced
8
Closed
12

Top Buys

Rank Stock Value
1
TECH icon
Bio-Techne
TECH
+$2.61M
2
MSFT icon
Microsoft
MSFT
+$1.81M
3
GPN icon
Global Payments
GPN
+$1.78M
4
SAGE
Sage Therapeutics
SAGE
+$1.37M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$951K

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$7.03M
2
SHPG
Shire pic
SHPG
+$2.89M
3
GILD icon
Gilead Sciences
GILD
+$2.4M
4
EVHC
Envision Healthcare Holdings Inc
EVHC
+$1.54M
5
MUR icon
Murphy Oil
MUR
+$1.51M

Sector Composition

Rank Sector Weight
1 Healthcare 33.61%
2 Energy 17.8%
3 Industrials 17.78%
4 Technology 10.38%
5 Financials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAC icon
26
Bank of America
BAC
$435B
$2.57M 0.89%
91,140
+8,614
+10% +$257K
GOOGL icon
27
Alphabet (Google) Class A
GOOGL
$3.91T
$2.51M 0.87%
44,460
+17,480
+65% +$951K
TEL icon
28
TE Connectivity
TEL
$58.8B
$2.45M 0.85%
27,199
+6,663
+32% +$638K
BMRN icon
29
BioMarin Pharmaceuticals
BMRN
$11.5B
$2.37M 0.82%
25,200
-7,200
-22% -$631K
NVDA icon
30
NVIDIA
NVDA
$5.01T
$2.22M 0.77%
375,080
+16,440
+5% +$99.9K
AMZN icon
31
Amazon
AMZN
$2.5T
$2.04M 0.71%
24,020
+3,520
+17% +$279K
IFF icon
32
International Flavors & Fragrances
IFF
$19.4B
$2.04M 0.71%
16,466
– –
V icon
33
Visa
V
$677B
$1.76M 0.61%
13,281
+2,079
+19% +$268K
SAGE
34
DELISTED
Sage Therapeutics
SAGE
$1.36M 0.47%
+8,700
New +$1.37M
SUPN icon
35
Supernus Pharmaceuticals
SUPN
$2.68B
$1.24M 0.43%
20,750
+5,750
+38% +$298K
SPGI icon
36
S&P Global
SPGI
$126B
$1.11M 0.38%
5,440
– –
ICE icon
37
Intercontinental Exchange
ICE
$82.4B
$1.07M 0.37%
14,504
+3,264
+29% +$238K
BDX icon
38
Becton Dickinson
BDX
$43.1B
$1.04M 0.36%
4,469
+737
+20% +$164K
BP icon
39
BP
BP
$113B
$1.04M 0.36%
24,224
-314
-1% -$13.2K
ABT icon
40
Abbott
ABT
$180B
$1.03M 0.36%
16,878
+11,999
+246% +$727K
CI icon
41
Cigna
CI
$76.6B
$951K 0.33%
5,597
+2,364
+73% +$409K
NSC icon
42
Norfolk Southern
NSC
$78.8B
$947K 0.33%
6,278
+990
+19% +$145K
COST icon
43
Costco
COST
$415B
$921K 0.32%
4,405
+1,135
+35% +$224K
HON icon
44
Honeywell
HON
$77.1B
$860K 0.3%
6,612
+2,941
+80% +$391K
HD icon
45
Home Depot
HD
$332B
$840K 0.29%
4,306
+804
+23% +$150K
DD icon
46
DuPont de Nemours
DD
$18.6B
$784K 0.27%
4,697
+670
+17% +$112K
TFX icon
47
Teleflex
TFX
$5.85B
$784K 0.27%
2,924
+727
+33% +$195K
ZAYO
48
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$743K 0.26%
20,359
+3,198
+19% +$114K
AVGO icon
49
Broadcom
AVGO
$1.82T
$718K 0.25%
+29,580
New +$725K
MAR icon
50
Marriott International
MAR
$98.7B
$703K 0.24%
5,556
+1,160
+26% +$158K
1
2
3 4

Similar funds

SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
EF
Empirical Finance Havertown, Pennsylvania $2.13B AUM 29.56% 1-Year Est. Return
NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
BCM
Basswood Capital Management New York $2.12B AUM 19.53% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

Aristotle Atlantic Partners's Q2 2018 Portfolio in Review

As of Q2 2018, Aristotle Atlantic Partners held 95 positions worth $288M, up 4.1% from $277M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Aristotle Atlantic Partners's Q2 2018 filing shows 4 new, 57 increased, 8 reduced and 12 closed positions. Its largest new stake was Sage Therapeutics: 8,700 shares worth $1.36M. The largest sale was Monsanto Co, an estimated $7.03M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 34% a quarter earlier, followed by Energy and Industrials.

  • Aristotle Atlantic Partners's largest Q2 2018 buy was Sage Therapeutics: 8,700 shares worth $1.36M.
  • Aristotle Atlantic Partners added most to Bio-Techne in Q2 2018, an estimated $2.61M increase.
  • Aristotle Atlantic Partners's biggest Q2 2018 reduction was Gilead Sciences, cutting an estimated $2.4M.
  • Aristotle Atlantic Partners fully exited Monsanto Co in Q2 2018, selling an estimated $7.03M.
  • Aristotle Atlantic Partners's ten largest holdings make up 61% of its $288M portfolio in Q2 2018.
  • Aristotle Atlantic Partners opened 4 new positions and closed 12 in Q2 2018.
  • Aristotle Atlantic Partners's portfolio value rose 4.1% quarter-over-quarter to $288M.

Based on Aristotle Atlantic Partners's 13F filing for Q2 2018, filed 14 Aug 2018.